Explore more publications!

Press Releases

Predictive Disease Analytics Market Size Grows at 22.75% CAGR by 2034 – Towards Healthcare
Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System
Generic Drug CRO Market Size to Climb to USD 11.73 Billion by 2034, reports Towards Healthcare
ACA Pharma Announces Major Expansion of RYANODEX® Territory Outside the United States
Nanobiotix Provides Third Quarter 2025 Operational and Financial Update Along With 2026 Clinical Outlook
Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025
ABL Diagnostics Announces Partnership with seqWell to Advance NGS Library Preparation for Infectious Disease
$95.5 + Billion Infant Nutrition Market to Grow at 7.7% CAGR by 2032
Sotheby’s Concierge Auctions: Reserve Met; Bidding Opens at €15M for Waterfront Estate on the French Riviera
Dietary Supplements Market Size to Reach USD 287.14 Billion by 2032 | Trends, Demand, Forecast & Competitive Analysis
Clinical Trials Support Software Solutions Market Size to Hit USD 30.78 Billion by 2034
Medical Flexible Packaging Market Size, Trends, Segments and Regional Data (NA/EU/APAC/LA/MEA) 2025-2035
Global and European Healthcare Natural Language Processing (NLP) Market Market Outlook 2025–2035
Nanox Partners with French Radiology Group Olympe Imagerie to Advance Clinical Validation in Europe
Beta Glucan Market Current and Future Trends, Analysis and Forecast by 2032
AI-Based Pharmaceutical R&D Services Market on a High-Growth Trajectory – report by Towards Healthcare
ABL Diagnostics and ELTA 90 Medical Science Win Tender to Deliver Whole Genome HIV Genotyping Solution in Montenegro
Cell and Gene Therapy Infrastructure Market Rising Opportunities - Towards Healthcare Insight
Global Healthcare Customer Data Platform Market Size/Share Worth USD 14.24 Billion by 2034 at a 32.10% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Gene Therapy for Ocular Rare Disease Market to Exhibit Phenomenal Growth During the Forecast Period (2025–2034) Due to Expanding Pipeline and Clinical Trial Activities | DelveInsight

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions